Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
05/10/2002 | WO2001028580A3 Modulation of angiogenesis |
05/10/2002 | WO2001027135A3 Regulators of the hedgehog pathway, compositions and uses related thereto |
05/10/2002 | WO2001024827A3 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
05/10/2002 | WO2001023386A3 Benzodiazepin derivatives, the production and use thereof |
05/10/2002 | WO2000073349A9 Dr4 antibodies and uses thereof |
05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
05/10/2002 | WO2000067736A3 Therapeutic use of an inhibitor or an antagonist of an abc protein in bone |
05/10/2002 | WO2000058339A3 50 human secreted proteins |
05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
05/10/2002 | CA2427795A1 Sustained release device for treating conditions of the joint |
05/10/2002 | CA2427613A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
05/10/2002 | CA2427572A1 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
05/10/2002 | CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity |
05/10/2002 | CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
05/10/2002 | CA2427394A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
05/10/2002 | CA2421705A1 New treatments for restless legs syndrome |
05/09/2002 | US20020055643 Tubulin binding ligands and corresponding prodrug constructs |
05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
05/09/2002 | US20020055538 Aspirin-triggered lipid mediators |
05/09/2002 | US20020055527 Thiazolium compounds and treatments of disorders associated with protein aging |
05/09/2002 | US20020055518 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
05/09/2002 | US20020055456 Therapeutic methods that target fractalkine or CX3CR1 |
05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
05/09/2002 | US20020054875 Administering to a patient of inflammatory arthritis a therapeutically effective amount of an antagonist of CX3CR1 function or fractalkine fucntion(a chemokine protein or antibody or newly discovered T-cell, a cell adhesion protein) |
05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
05/08/2002 | EP1203764A1 Benzamidine derivatives with LTB4-antagonistic activity |
05/08/2002 | EP1203761A2 Calcium receptor-active compounds |
05/08/2002 | EP1203583A1 Remedies for arthrosis deformans |
05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
05/08/2002 | EP1203092A1 Antisense modulation of map kinase kinase 6 expression |
05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
05/08/2002 | EP1203005A2 25 human secreted proteins |
05/08/2002 | EP1202999A1 Novel 2-decarboxy-2-phosphinico prostaglandin f analogs |
05/08/2002 | EP1202994A1 New compounds |
05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
05/08/2002 | EP1202984A1 Novel diphenyl-piperidine derivate |
05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
05/08/2002 | EP1202959A1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
05/08/2002 | EP1202957A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
05/08/2002 | EP1202954A1 Novel aminobenzophenones |
05/08/2002 | EP1202755A1 Cartilage or bone matrix as a nucleic acid delivery vehicle |
05/08/2002 | EP1202743A2 Fish serine proteinases and their pharmaceutical and cosmetic use |
05/08/2002 | EP1202734A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
05/08/2002 | EP1202733A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
05/08/2002 | EP1202723A2 Use of anti-muscarinic agents for treating skin disorders |
05/08/2002 | EP1202705A2 Composition for restoring defects in calcified tissues |
05/08/2002 | DE10054278A1 Verwendung von Stimulatoren der löslichen Guanylatcyclase zur Behandlung von Osteoporose Use of stimulators of soluble guanylate cyclase for the treatment of osteoporosis |
05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
05/08/2002 | CN1348439A New compounds, their preparation and use |
05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
05/08/2002 | CN1348365A Chewing gum with dental benefits including calcium in a food grade acid |
05/08/2002 | CN1347731A Externally applied Chinese medicine prepn for treating lumbar vertebra disease |
05/08/2002 | CN1347728A Chinese medicine prepn for treating rheumatic osteoarthropathy |
05/08/2002 | CN1347707A Externally applied bone Bi-syndrome treating plaster and its prepn |
05/08/2002 | CN1347704A Family handed traditional Chinese medicine recipe of osteomyelitis treatment |
05/08/2002 | CN1084207C Medicinal liquor and ointment for treating traumatic injury |
05/08/2002 | CN1084197C Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process |
05/07/2002 | US6384202 Cell-specific active compounds regulated by the cell cycle |
05/07/2002 | US6384042 Systemic use of 5-HT3 receptor antagonists against rheumatic inflammatory processes |
05/07/2002 | US6384041 Bicyclic sPLA2 inhibitors |
05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
05/07/2002 | US6383790 Pyrazolo(3,4-d)pyrimidine based compound; anticarcinogenic agents; antitumor agents |
05/07/2002 | US6383780 2786, a novel human aminopeptidase |
05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
05/07/2002 | CA2361071A1 Combination therapies for the stimulation of bone growth |
05/02/2002 | WO2002035235A2 Net as regulator of angiogenic expression |
05/02/2002 | WO2002034940A2 Methods for screening compounds that modulate lipid metabolism |
05/02/2002 | WO2002034895A2 Novel aggrecanase molecules |
05/02/2002 | WO2002034783A2 Transmembrane proteins |
05/02/2002 | WO2002034767A1 Vegf peptides and their use for inhibiting angiogenesis |
05/02/2002 | WO2002034761A1 Pyranoside derivatives |
05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/02/2002 | WO2002034747A1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
05/02/2002 | WO2002034741A2 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |
05/02/2002 | WO2002034726A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
05/02/2002 | WO2002034721A1 Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors |
05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
05/02/2002 | WO2002034303A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
05/02/2002 | WO2002034280A2 Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with pain |
05/02/2002 | WO2002034252A1 Drug composition comprising dipeptydyl aldehyde derivative |
05/02/2002 | WO2002034240A2 Delayed and sustained release formulations and method of use thereof |
05/02/2002 | WO2002034236A2 Lipid formulations for target delivery |
05/02/2002 | WO2002034204A2 Calcilytic compounds |
05/02/2002 | WO2002034202A2 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
05/02/2002 | WO2001098330A3 A RECOMBINANT CELL LINE EXPRESSING GPCRx11 AS A FUNCTIONAL RECEPTOR VALIDATED BY ANGIOPEPTIN AND USEFUL FOR SCREENING OF AGONISTS AND ANTAGONISTS |
05/02/2002 | WO2001096397A3 Cd154 variants and uses thereof |
05/02/2002 | WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |